Skip to Content

Jihan M. Saba, MD, FACR

photo of Dr. Jihan M. Saba
Telephone: 
(954) 229-8660
Fax: 
(954) 229-8659
Languages: 
English
Arabic
Specialty/Specialties: 
Rheumatology
Holy Cross Medical Group: 
Yes

Office Hours
Tues-Thurs  8:30am to 2:15pm


Focus Areas
Rheumatology, Rheumatoid Arthritis, Inflammatory Arthritis


Certification
American Board of Internal Medicine - Rheumatology


Residency / Fellowship
Fellowship, Rheumatology - Alton Ochsner Medical Foundation - New Orleans, LA (1997-1999)
Residency, Internal Medicine - Norwalk Hospital / Yale University - Norwalk, CT (1994-1997)
Residency, Rheumatology - Cairo University Hospitals - Cairo, Egypt (1993-1994)
Internship, Rotating - Cairo University Hospitals - Cairo, Egypt (1992-1993)


Higher Education
Cairo University Faculty of Medicine, M.B., B.Ch. - Cairo, Egypt (1985-1991)


Professional Associations
American College of Rheumatology


Awards
Graduated with Honors (95th percentile), Cairo University Faculty of Medicine (1991)
Pathology Award, Cairo University Faculty of Medicine (1988)


Research
CD-40 ligand expression on T cells in SLE and Rheumatoid Arthritis.


A multi-center, randomized parallel group, placebo controlled, double-blind study with in house blinding to determine the effect of 156 weeks of treatment with MK-0966 on the recurrence of neoplastic polyps of the large bowel in patients wiht a history of colonic adenomas. Merck & Co.


A prospective, multicenter, randomized, double-blind, active comparator controlled, parallel groups study comparing the fully human monoclonal anti-TNFa antibody D2E7 given every second week with methotrexate given weekly and the combination of D2E7 and methotrexate administered over two years in patients with early rheumatoid arthritis. Knoll Pharmaceutical.


A double-blind, placebo and active comparator controlled parallel group study to assess the safety and efficacy of MK-0663 in ankylosing spondylitis. Merck & Co.


A phase III prospective, randomized, double-blind, 3 arm, multicenter study to compare the efficacy and safety of celecoxib 200 mg BID, and celecoxib 400 mg versus placebo in reducing the occurrence of new adenomatous polyps in the colorectum at year 1 and year 3 after endoscopic polypectomy. G.D. Searle & Co.


A one year, randomized placebo and active comparator controlled, parallel group, double-blind, two-part study to assess the safety and efficacy of MK-0663 versus naprosyn in patients with osteoarthritis. Merck & Co.


Health economic evaluation in conjuction with clinical trial DE013, a prospective multi-center, randomized, double-blind, active comparator controlled, parallel groups trial comparing the fully human monoclonal anti TNFa antibody D2E7 given every second week with methotrexate given weekly and the combination of D2E7 and methotrexate administered over two years in patients with early rheumatoid arthritis. Knoll Pharmaceutical.


Publications
Phrenic Nerve Paralysis Secondary to Lyme Neuroborreliosis. S Ishaq, R Quinet and J Saba. Neurology. 2002 Dec 10; 59(11):1810-1.


Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in SLE (m-SLAM). J Saba, R Quinet, W Davis, L Serebro, P Nair. Joint Bone Spine. 2003 Sept; 70(5): 348-51.


Presentations
Milk-Alkali Syndrome: A case report. J. Saba. Poster presentation: Spring Scientific Session, ACP: Connecticut Chapter. April 1997.


CD40L expression of peripheral blood T cells in Systemic Lupus Erythematosus and Rheumatoid Arthritis may be a reliable indicator of the inflammatory process. J. Saba, R. Quinet, J. Choe, J. Waxman, W. Davis, L. Serebro. Poster presentation: Fifth International Conference on SLE. Cancun, Mexico. April 20-25, 1998. Abstract: Lupus. Vol. 7 Supplement 1: 57 1998.


Discovery of Automimmune Hepatitis During Methotrexate Therapy for Systemic Lupus Erythematosus. J. Saba, R. Quinet. Poster presentation: Fifth International Conference on SLE. Cancun, Mexico. April 20-25, 1998. Abstract: Lupus. Vol. 7 S1: 90 1998.


Lyme disease manifesting as a triad of left phrenic nerve paralysis, left facial palsy and lymphocytic meningitis. J. Saba, S. Rai, R. Quinet. Poster presentation: XII Panamerican Congress of Rheumatology, Montreal, Canada, June 21-25, 1998. Abstract: J. Rheum. Vol. 25 S52: 33 June 1998.


Rheumatoid Arthritis: An initial manifestation of Wegener's Granulomatosis? S. Rai, J. Saba, J. Waxman, R. Quinet. Poster presentation: XII Panamerican Congress of Rheumatology, Montreal, Canada June 21-25 1998. Abstract: J. Rheum. Vol. 25 S52: 83 June 1998.


Longest reported survivor of neonatal multisystem inflammatory disease (NOMID). Priya Nair, Robert Quinet, William Davis, Leonard Serebro and Jihan Saba. Poster presentation: Southern Medical Association, Dallas, TX. Nov 10-12, 1999.


Malignancy presenting as Tietze's syndrome (Costochondritis). Priya Nair, Robert Quinet, William Davis, Leonard Serebro and Jihan Saba. Poster presentation: Southern Medical Association, Dallas, TX. Nov 10-12, 1999.

Location

1000 NE 56th Street
Fort Lauderdale, FL 33334

HCMG Practice Locations

Map

My Health Patient Portal